Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice

Infection and Immunity

Volumn 77, Issue 4, 2009, Pages 1708-1718

  Rhee, Ki Jong ^a,f   Wu, Shaoguang ^a   Wu, Xinqun ^a   Huso, David L ^b,c   Karim, Baktiar ^b   Franco, Augusto A ^a   Rabizadeh, Shervin ^a   Golub, Jonathan E ^a   Mathews, Lauren E ^a   Shin, Jai ^a   Balfour Sartor, R ^d   Golenbock, Douglas ^e   Hamad, Abdel R ^a   Gan, Christine M ^a   Housseau, Franck ^a,c   Sears, Cynthia L ^a,c  

^a Department of Medicine ^*  (United States)

^b Molecular and Comparative Pathobiology   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRAGILYSIN; INTERLEUKIN 8; TOLL LIKE RECEPTOR; UVOMORULIN; VIRULENCE FACTOR; BACTERIAL TOXIN; ENTEROTOXIN; METALLOPROTEINASE;

ABSCESS; ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTEROIDES FRAGILIS; BFT GENE; CELL ACTIVATION; CELL INFILTRATION; CELL PROLIFERATION; CELL STIMULATION; COLITIS; COLORECTAL CANCER; COMMENSAL; CONTROLLED STUDY; CRYPT CELL; CYTOKINE RELEASE; DENDRITIC CELL; DIARRHEA; EMBRYO; ENTERITIS; EPITHELIUM CELL; EROSION; GENE; GENE MUTATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VIVO STUDY; INTESTINE EPITHELIUM; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; ULCER; WILD TYPE; ANIMAL; BACTEROIDES INFECTION; C57BL MOUSE; CELL CULTURE; CELL LINE; COLON; CYTOLOGY; DISEASE MODEL; GERMFREE ANIMAL; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY;

ANIMALS; BACTERIAL TOXINS; BACTEROIDES FRAGILIS; BACTEROIDES INFECTIONS; CELL LINE; CELLS, CULTURED; COLITIS; COLON; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; ENTEROTOXINS; GERM-FREE LIFE; HUMANS; METALLOENDOPEPTIDASES; MICE; MICE, INBRED C57BL; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 63149120571     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00814-08     Document Type: Article

References (61)

1. Barthel, M., S. Hapfelmeier, L. Quintanilla-Martinez, M. Kremer, M. Ro- hde, M. Hogardt, K. Pfeffer, H. Russmann, and W. D. Hardt. 2003. Pretreat- ment of mice with streptomycin provides a Salmonella enterica serovar Ty- phimurium colitis model that allows analysis of both pathogen and host. Infect. Immun. 71:2839-2858.
2. Basset, C., J. Holton, A. Bazeos, D. Vaira, and S. Bloom. 2004. Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease? Dig. Dis. Sci. 49:1425-1432.
3. Chambers, F. G., S.S. Koshy, R. F.Saidi, D. P.Clark, R. D. Moore, and C. L. Sears. 1997. Bacteroides fragilis toxin exhibits polar activity on monolayers of human intestinal epithelial cells (T84 cells) in vitro. Infect. Immun. 65:3561-3570.
4. Chung, G. T., A. A. Franco, S. Wu, G. E. Rhie, R. Cheng, H. B. Oh, and C. L. Sears. 1999. Identification of a third metalloprotease toxin gene in extraint- estinal isolates of Bacteroides fragilis. Infect. Immun. 67:4945-4949.
5. Coyne, M. J., W. Kalka-Moll, A. O. Tzianabos, D. L. Kasper, and L. E. Comstock. 2000. Bacteroides fragilis NCTC9343 produces at least three distinct capsular polysaccharides: cloning, characterization, and reassignment of polysaccharide B and C biosynthesis loci. Infect. Immun. 68:6176-6181.
6. Coyne, M. J., K. G. Weinacht, C. M. Krinos, and L. E. Comstock. 2003. Mpi recombinase globally modulates the surface architecture of a human commensal bacterium. Proc. Natl. Acad. Sci. USA 100:10446-10451.
7. Elson, C. O., Y. Cong, V. J. McCracken, R. A. Dimmitt, R. G. Lorenz, and C. T. Weaver. 2005. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol. Rev. 206:260-276.
8. Franco, A. A., S. L. Buckwold, J. W. Shin, M. Ascon, and C. L. Sears. 2005. Mutation of the zinc-binding metalloprotease motif affects Bacteroides fra- gilis toxin activity but does not affect propeptide processing. Infect. Immun. 73:5273-5277.
9. Franco, A. A., R. K. Cheng, A. Goodman, and C. L. Sears. 2002. Modulation of bft expression by the Bacteroides fragilis pathogenicity island and its flanking region. Mol. Microbiol. 45:1067-1077.
10. Franco, A. A., L. M. Mundy, M. Trucksis, S. Wu, J. B. Kaper, and C. L. Sears. 1997. Cloning and characterization of the Bacteroides fragilis metal- loprotease toxin gene. Infect. Immun. 65:1007-1013.
11. Gupta, A., H. Vlamakis, N. Shoemaker, and A. A. Salyers. 2003. A new Bacteroides conjugative transposon that carries an ermB gene. Appl. Environ. Microbiol. 69:6455-6463.
12. He, T. C., A. B. Sparks, C. Rago, H. Hermeking, L. Zawel, L. T. da Costa, P. J. Morin, B. Vogelstein, and K. W. Kinzler. 1998. Identification of c-MYC as a target of the APC pathway. Science 281:1509-1512.
13. Hermiston, M. L., M. H. Wong, and J. I. Gordon. 1996. Forced expression of E-cadherin in the mouse intestinal epithelium slows cell migration and provides evidence for nonautonomous regulation of cell fate in a self-renewing system. Genes Dev. 10:985-996.
14. Hise, A. G., K. Daehnel, I. Gillette-Ferguson, E. Cho, H. F. McGarry, M. J. Taylor, D. T. Golenbock, K. A. Fitzgerald, J. W. Kazura, and E. Pearlman. 2007. Innate immune responses to endosymbiotic Wolbachia bacteria in Brugia malayi and Onchocerca volvulus are dependent on TLR2, TLR6, MyD88, and Mal, but not TLR4, TRIF, or TRAM. J. Immunol. 178:1068-1076.
15. Högenauer, C., C. Langner, E. Beubler, I. T. Lippe, R. Schicho, G. Gork- iewicz, R. Krause, N. Gerstgrasser, G. J. Krejs, and T. A. Hinterleitner. 2006. Klebsiella oxytoca as a causative organism of antibiotic-associated hemor-rhagic colitis. N. Engl. J. Med. 355:2418-2426.
16. Hollander, D., C. M. Vadheim, E. Brettholz, G. M. Petersen, T. Delahunty, and J. I. Rotter. 1986. Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. Ann. Intern. Med. 105:883-885.
17. Kim, J. M., J. Y. Lee, Y. M. Yoon, Y. K. Oh, J. S. Kang, Y. J. Kim, and K. H. Kim. 2006. Bacteroides fragilis enterotoxin induces cyclooxygenase-2 and fluid secretion in intestinal epithelial cells through NF-KB activation. Eur. J. Immunol. 36:2446-2456.
18. Kim, J. M., Y. K. Oh, Y. J. Kim, H. B. Oh, and Y. J. Cho. 2001. Polarized secretion of CXC chemokines by human intestinal epithelial cells in response to Bacteroides fragilis enterotoxin: NF-KB plays a major role in the regulation of IL-8 expression. Clin. Exp. Immunol. 123:421-427.
19. Kling, J. J., R. L. Wright, J. S. Moncrief, and T. D. Wilkins. 1997. Cloning and characterization of the gene for the metalloprotease enterotoxin of Bacteroides fragilis. FEMS Microbiol. Lett. 146:279-284.
20. Konrad, A., Y. Cong, W. Duck, R. Borlaza, and C. O. Elson. 2006. Tight mucosal compartmentation of the murine immune response to antigens of the enteric microbiota. Gastroenterology 130:2050-2059.
21. Krinos, C. M., M. J. Coyne, K. G. Weinacht, A. O. Tzianabos, D. L. Kasper, and L. E. Comstock. 2001. Extensive surface diversity of a commensal microorganism by multiple DNA inversions. Nature 414:555-558.
22. Kuhn, R., J. Lohler, D. Rennick, K. Rajewsky, and W. Muller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263-274.
23. Lu, W., A. Hisatsune, T. Koga, K. Kato, I. Kuwahara, E. P. Lillehoj, W. Chen, A. S. Cross, S. J. Gendler, A. T. Gewirtz, and K. C. Kim. 2006. Cutting edge: enhanced pulmonary clearance of Pseudomonas aeruginosa by Muc1 knockout mice. J. Immunol. 176:3890-3894.
24. Lu, Z., L. Yuan, X. Zhou, E. Sotomayor, H. I. Levitsky, and D. M. Pardoll. 2000. CD40-independent pathways of T cell help for priming of CD8+ cytotoxic T lymphocytes. J. Exp. Med. 191:541-550.
25. Luperchio, S. A., and D. B. Schauer. 2001. Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia. Microbes Infect. 3:333-340.
26. Mazmanian, S. K., C. H. Liu, A. O. Tzianabos, and D. L. Kasper. 2005. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122:107-118.
27. Moncrief, J. S., R. Obiso, Jr., L. A. Barroso, J. J. Kling, R. L. Wright, R. L. Van Tassell, D. M. Lyerly, and T. D. Wilkins. 1995. The enterotoxin of Bacteroides fragilis is a metalloprotease. Infect. Immun. 63:175-181.
28. Mundy, L. M., and C. L. Sears. 1996. Detection of toxin production by Bacteroides fragilis: assay development and screening of extraintestinal clinical isolates. Clin. Infect. Dis. 23:269-276.
29. Myers, L. L., and D. S. Shoop. 1987. Association of enterotoxigenic Bacteroides fragilis with diarrheal disease in young pigs. Am. J. Vet. Res. 48:774-775.
30. Myers, L. L., D. S. Shoop, J. E. Collins, and W. C. Bradbury. 1989. Diarrheal disease caused by enterotoxigenic Bacteroides fragilis in infant rabbits. J. Clin. Microbiol. 27:2025-2030.
31. Nakano, V., D. A. Gomes, R. M. Arantes, J. R. Nicoli, and M. J. Avila-Campos. 2006. Evaluation of the pathogenicity of the Bacteroides fragilis toxin gene subtypes in gnotobiotic mice. Curr. Microbiol. 53:113-117.
32. Obiso, R. J., Jr., A. O. Azghani, and T. D. Wilkins. 1997. The Bacteroides fragilis toxin fragilysin disrupts the paracellular barrier of epithelial cells. Infect. Immun. 65:1431-1439.
33. Obiso, R. J., Jr., D. M. Lyerly, R. L. Van Tassell, and T. D. Wilkins. 1995. Proteolytic activity of the Bacteroides fragilis enterotoxin causes fluid secretion and intestinal damage in vivo. Infect. Immun. 63:3820-3826.
34. Okayasu, I., S. Hatakeyama, M. Yamada, T. Ohkusa, Y. Inagaki, and R. Nakaya. 1990. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98:694-702.
35. Pantosti, A., A. O. Tzianabos, B. G. Reinap, A. B. Onderdonk, and D. L. Kasper. 1993. Bacteroides fragilis strains express multiple capsular polysac-charides. J. Clin. Microbiol. 31:1850-1855.
36. Prindiville, T. P., R. A. Sheikh, S. H. Cohen, Y. J. Tang, M. C. Cantrell, and J. Silva, Jr. 2000. Bacteroides fragilis enterotoxin gene sequences in patients with inflammatory bowel disease. Emerg. Infect. Dis. 6:171-174.
37. Rabizadeh, S., K.-J. Rhee, S. Wu, D. Huso, C. M. Gan, J. E. Golub, X. Wu, M. Zhang, and C. L. Sears. 2007. Enterotoxigenic Bacteroides fragilis:a potential instigator of colitis. Inflamm. Bowel Dis. 13:1475-1483.
38. Riegler, M., M. Lotz, C. Sears, C. Pothoulakis, I. Castagliuolo, C. C. Wang, R. Sedivy, T. Sogukoglu, E. Cosentini, G. Bischof, W. Feil, B. Teleky, G. Hamilton, J. T. LaMont, and E. Wenzl. 1999. Bacteroides fragilis toxin 2 damages human colonic mucosa in vitro. Gut 44:504-510.
39. Robertson, K. P., C. J. Smith, A. M. Gough, and E. R. Rocha. 2006. Characterization of Bacteroides fragilis hemolysins and regulation and synergistic interactions of HlyA and HlyB. Infect. Immun. 74:2304-2316.
40. Sack, R. B., L. L. Myers, J. Almeido-Hill, D. S. Shoop, W. C. Bradbury, R. Reid, and M. Santosham. 1992. Enterotoxigenic Bacteroides fragilis: epide- miologic studies of its role as a human diarrhoeal pathogen. J. Diarrhoeal Dis. Res. 10:4-9.
41. Sadlack, B., H. Merz, H. Schorle, A. Schimpl, A. C. Feller, and I. Horak. 1993. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75:253-261.
42. Sanfilippo, L., C. K. Li, R. Seth, T. J. Balwin, M. G. Menozzi, and Y. R. Mahida. 2000. Bacteroides fragilis enterotoxin induces the expression of IL-8 and transforming growth factor-beta (TGF-|3) by human colonic epithelial cells. Clin. Exp. Immunol. 119:456-463.
43. Scotto d'Abusco, A. S., L. Sanfilippo, M. G. Menozzi, and A. Pantosti. 2000. Activity and role of BFT, an enterotoxin produced by Bacteroides fragilis J. Nat. Toxins 9:267-280.
44. Sears, C. L. 2001. The toxins of Bacteroides fragilis. Toxicon 39:1737-1746.
45. Sears, C. L., S. Islam, A. Saha, M. Arjumand, N. H. Alam, A. S. Faruque, M. A. Salam, J. Shin, D. Hecht, A. Weintraub, R. B. Sack, and F. Qadri. 2008. Association of enterotoxigenic Bacteroides fragilis infection with inflammatory diarrhea. Clin. Infect. Dis. 47:797-803.
46. Shanson, D. C., and J. Singh. 1981. Effect of adding cysteine to brain-heart infusion broth on the isolation of Bacteroides fragilis from experimental blood cultures. J. Clin. Pathol. 34:221-223.
47. Stevens, A. M., N. B. Shoemaker, and A. A. Salyers. 1990. The region of a Bacteroides conjugal chromosomal tetracycline resistance element which is responsible for production of plasmidlike forms from unlinked chromosomal DNA might also be involved in transfer of the element. J. Bacteriol. 172: 4271-4279.
48. Teahon, K., P. Smethurst, A. J. Levi, I. S. Menzies, and I. Bjarnason. 1992. Intestinal permeability in patients with Crohn's disease and their first degree relatives. Gut 33:320-323.
49. Tetsu, O., and F. McCormick. 1999. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422-426.
50. Toprak, N. U., A. Yagci, B. M. Gulluoglu, M. L. Akin, P. Demirkalem, T. Celenk, and G. Soyletir. 2006. A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer. Clin. Microbiol. Infect. 12:782-786.
51. Van Tassell, R. L., D. M. Lyerly, and T. D. Wilkins. 1992. Purification and characterization of an enterotoxin from Bacteroides fragilis. Infect. Immun. 60:1343-1350.
52. Vines, R. R., S. S. Perdue, J. S. Moncrief, D. R. Sentz, L. A. Barroso, R. L. Wright, and T. D. Wilkins. 2000. Fragilysin, the enterotoxin from Bacteroides fragilis, enhances the serum antibody response to antigen co-administered by the intranasal route. Vaccine 19:655-660.
53. 1, treated with crude Bacteroides fragilis enterotoxin dramatically alter their morphology. Infect. Immun. 60: 321-327.
54. Wilkins, T. D., and S. Chalgren. 1976. Medium for use in antibiotic susceptibility testing of anaerobic bacteria. Antimicrob. Agents Chemother. 10: 926-928.
55. Wu, S., L. A. Dreyfus, A. O. Tzianabos, C. Hayashi, and C. L. Sears. 2002. Diversity of the metalloprotease toxin produced by enterotoxigenic Bacte- roides fragilis. Infect. Immun. 70:2463-2471.
56. Wu, S., K. C. Lim, J. Huang, R. F. Saidi, and C. L. Sears. 1998. Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin. Proc. Natl. Acad. Sci. USA 95:14979-14984.
57. Wu, S., P. J. Morin, D. Maouyo, and C. L. Sears. 2003. Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation. Gastroen-terology 124:392-400.
58. Wu, S., J. Powell, N. Mathioudakis, S. Kane, E. Fernandez, and C. L. Sears. 2004.Bacteroidesfragilisenterotoxininducesintestinalepithelialcellsecretionof interleukin-8 through mitogen-activated protein kinases and a tyrosine kinase- regulated nuclear factor-κB pathway. Infect. Immun. 72:5832-5839.
59. Wu, S., K.-J. Rhee, M. Zhang, A. Franco, and C. L. Sears. 2007. Bacteroides fragilis toxin stimulates intestinal epithelial cell shedding and γ-secretase- dependent E-cadherin cleavage. J. Cell Sci. 120:1944-1952.
60. Wu, S., J. Shin, G. Zhang, M. Cohen, A. Franco, and C. L. Sears. 2006. The Bacteroides fragilis toxin binds to a specific intestinal epithelial cell receptor. Infect. Immun. 74:5382-5390.
61. Zbar, A. P., C. Simopoulos, and A. J. Karayiannakis. 2004. Cadherins: an integral role in inflammatory bowel disease and mucosal restitution. J. Gas-troenterol. 39:413-421.